Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Eoganacht


V.TLT

New Article from journal Bladder Cancer mentions TLD1433 PDT

This article deals witht current and emerging bladder cancer treatments. It...

May 9, 2023

V.TLT

RE:RE:RE:RE:RE:Question about AUA Swimmer's Plot

Thanks Enrique/ScienceFirst/wildbird/DjDawg/CancerSlayer et al. The mists are...

May 9, 2023

V.TLT

RE:RE:RE:Question about AUA Swimmer's Plot

Thanks for that CancerSlayer. CancerSlayer wrote: CancerSlayer wrote...

May 8, 2023

V.TLT

Question about AUA Swimmer's Plot

There are a few rows in the AUA Swimmer's Plot I don't get. I wonder...

May 8, 2023

V.TLT

Spanish Researchers inspired by success of TLD1433

The research group of Dr.Jos Ruiz Lpez at the University of Murcia in Spain...

May 7, 2023

V.TLT

From 2021 but still relevant...

Quotes from Dr. McFarland:   “TLD-1433 is extremely effective at...

May 6, 2023

V.TLT

RE:RE:RE:RE:Finances

Absolutely. IMHO the next step is demonstrating proof of concept for low...

May 5, 2023

V.TLT

RE:RE:Finances

I vote for a JV. It would be a terrible shame to have a buyout at this stage...

May 5, 2023

V.TLT

RE:RE:Theralase MSAB

I'm guessing partly an economy measure and partly clearing the deck for...

May 5, 2023

V.TLT

RE:RE:Theralase MSAB

Yes, I'm also guessing it's an economy measure. The MSAB has had only...

May 5, 2023

V.TLT

Theralase MSAB

Our Medical and Scientific Advisory Board now consists of just one member...

May 5, 2023

V.TLT

RE:RE:RE:RE:RE:Patients who remained in Study 2

Just one more senior moment. I meant to write - 40% - 50% complete durable...

May 4, 2023

V.TLT

RE:RE:RE:RE:Patients who remained in Study 2

I very much hope yours is the correct interpretation Enrique. If it is we...

May 3, 2023

V.TLT

RE:Patients who remained in Study 2

The phrase "...patients who remained in Study II" is ambiguous. It...

May 3, 2023

V.TLT

RE:RE:Trial Result Tables

Thanks CancerSlayer - I think it's looking very good. A durable complete...

May 3, 2023

V.TLT

RE:RE:Trial Result Tables

Yes it was a typo - it should be 450. Thanks Infinity. Infinity wrote...

May 2, 2023

V.TLT

Trial Result Tables

Below are 3 trial result tables.None of the 3 tables include the phase 1...

May 2, 2023

V.TLT

RE:RE:RE:Combination drugs

It looks like they're going to do a phase 3. enriquesuave wrote...

May 2, 2023

V.TLT

News in 4 Weeks

We should be getting another MD&A at the end of May. 

May 1, 2023

V.TLT

Theralase AUA Poster

AUA 2023 Theralase Poster It looks like data presentation is the same as the...

May 1, 2023

Featured Company